Dr Reddy’s launches generic version of Plaquenil in US
Team Udayavani, Jul 11, 2018, 4:39 PM IST
New Delhi: Dr Reddy’s Laboratories today announced the launch of generic version of Plaquenil, used to treat malaria, lupus erythematosus, and rheumatoid arthritis, in the US.
The launch follows approval of Hydroxychloroquine Sulfate tablets, a therapeutic equivalent generic version of Plaquenil, by the US Food and Drug Administration (USFDA), Dr Reddy’s Laboratories said in a BSE filing.
Quoting IMS Health data, Dr Reddy’s Laboratories the Plaquenil brand and generic had US sales of approximately USD 215 million for the most recent twelve months ending in May 2018.
Dr Reddy’s said its product Hydroxychloroquine Sulfate tablets are available in 200 mg tablets in the bottle count sizes of 100 and 500.
Plaquenil is a trademark of Concordia International Corp.
Shares of Dr Reddy’s Laboratories were trading at Rs 2,293.95 apiece, down 1.11 per cent from the previous close on the BSE.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Epigamia founder Rohan Mirchandani dies of cardiac arrest at age 42
Lohia Auto launches EV brand ‘Youdha’, aims to sell 3 lakh vehicles by 2027
“FM ji FM ji, itna tax main kaise bharun”, asks investor Vijay Kedia in viral post
RBI: After another status quo year, all eyes on a growth-propping rate cut with new Guv at helm
Front-running case: Sebi bans 9 entities from market , impounds illegal gains of over Rs 21 crore
MUST WATCH
Latest Additions
Kalaburagi: Woman sustains burns after live electric wire falls on her
Nelamangala accident: Police expedite probe, CCTV images being scrutinised
Rohan Estate Mukka – Resort-style luxury layout launched
Minister Parameshwara directs police to ensure tight security in Bengaluru on New Year’s eve
Teachings of Lord Christ celebrate love, harmony: PM Modi at Christmas celebrations
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.